383 related articles for article (PubMed ID: 12894198)
21. Follow-on biologics: competition in the biopharmaceutical marketplace.
Devine JW; Cline RR; Farley JF
J Am Pharm Assoc (2003); 2006; 46(2):193-201; quiz 202-4. PubMed ID: 16602229
[TBL] [Abstract][Full Text] [Related]
22. Investigating investment in biopharmaceutical R&D.
Carter PH; Berndt ER; DiMasi JA; Trusheim M
Nat Rev Drug Discov; 2016 Oct; 15(10):673-4. PubMed ID: 27616295
[TBL] [Abstract][Full Text] [Related]
23. Trends in antimicrobial drug development: implications for the future.
Spellberg B; Powers JH; Brass EP; Miller LG; Edwards JE
Clin Infect Dis; 2004 May; 38(9):1279-86. PubMed ID: 15127341
[TBL] [Abstract][Full Text] [Related]
24. Russia through the prism of the world biopharmaceutical market.
Bairamashvili DI; Rabinovich ML
Biotechnol J; 2007 Jul; 2(7):801-17. PubMed ID: 17615600
[TBL] [Abstract][Full Text] [Related]
25. A perfect storm for innovation.
Williams RN
Clin Pharmacol Ther; 2010 Jul; 88(1):23; author reply 23-4. PubMed ID: 20445532
[No Abstract] [Full Text] [Related]
26. Biopharma in Piedmont, Italy.
Sakariassen KS
Nat Rev Drug Discov; 2005 Jun; 4(6):519. PubMed ID: 15959953
[No Abstract] [Full Text] [Related]
27. New drug approvals for 2002.
Frantz S; Smith A
Nat Rev Drug Discov; 2003 Feb; 2(2):95-6. PubMed ID: 12572538
[No Abstract] [Full Text] [Related]
28. Biotechnology's metamorphosis into a drug discovery industry.
Drews J
Nat Biotechnol; 1998 May; 16 Suppl():22-4. PubMed ID: 9591258
[No Abstract] [Full Text] [Related]
29. Prospects for productivity.
Booth B; Zemmel R
Nat Rev Drug Discov; 2004 May; 3(5):451-6. PubMed ID: 15136792
[No Abstract] [Full Text] [Related]
30. Recombinant protein therapeutics--success rates, market trends and values to 2010.
Pavlou AK; Reichert JM
Nat Biotechnol; 2004 Dec; 22(12):1513-9. PubMed ID: 15583654
[No Abstract] [Full Text] [Related]
31. A rollercoaster ride.
Jacobs T
Nat Biotechnol; 2006 Mar; 24(3):284. PubMed ID: 16525390
[No Abstract] [Full Text] [Related]
32. Venturing into drug discovery.
Steinmetz M
Nat Biotechnol; 1998 May; 16 Suppl():17. PubMed ID: 9591255
[No Abstract] [Full Text] [Related]
33. An overview of the pharmaceutical industry.
Stave GM; Joines R
Occup Med; 1997; 12(1):1-4. PubMed ID: 9153049
[TBL] [Abstract][Full Text] [Related]
34. Mobile economics and pricing of health care services.
Huttin CC
Technol Health Care; 2012; 20(5):459-61. PubMed ID: 23079949
[TBL] [Abstract][Full Text] [Related]
35. A merger too far?
Wadman M
Nature; 2007 Mar; 446(7131):15. PubMed ID: 17330017
[No Abstract] [Full Text] [Related]
36. The origins of new drugs.
Kneller R
Nat Biotechnol; 2005 May; 23(5):529-30. PubMed ID: 15877061
[No Abstract] [Full Text] [Related]
37. The farmyard drug store.
Nature; 2006 Sep; 443(7107):16-7. PubMed ID: 16957702
[No Abstract] [Full Text] [Related]
38. Pharmaceutical research: cost savings through innovation.
Cohen KR; Levy RA
AAPPO J; 1993 Oct; 3(5):28-36. PubMed ID: 10146463
[No Abstract] [Full Text] [Related]
39. Pharmaceutical industry.
Lewis L
State Health Care Am; 1994; ():23-7. PubMed ID: 10133845
[TBL] [Abstract][Full Text] [Related]
40. The power of genomics to transform the biotechnology industry.
Haseltine WA
Nat Biotechnol; 1998 May; 16 Suppl():25-7. PubMed ID: 9591259
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
